Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
about
Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells is a primary target for therapy with tyrosine kinase inhibitorsBlood vessels as targets in tumor therapyDisplay technologies: application for the discovery of drug and gene delivery agents.Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model.Inhibition of epidermal growth factor receptor and vascular endothelial growth factor receptor phosphorylation on tumor-associated endothelial cells leads to treatment of orthotopic human colon cancer in nude miceMolecular biology of epidermal growth factor receptor inhibition for cancer therapy.Therapeutic options to target angiogenesis in human malignancies.DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitroEmerging therapies: angiogenesis inhibitors for ovarian cancer.Phorbol ester-induced shedding of the prostate cancer marker transmembrane protein with epidermal growth factor and two follistatin motifs 2 is mediated by the disintegrin and metalloproteinase-17.Targeting tumour microenvironment by tyrosine kinase inhibitor.
P2860
Q24644787-F528F9D8-0A11-4F4D-A8C3-D325302858F0Q28590737-F1A58DDB-8194-4C88-927C-AEE2EBF95B85Q33264491-9CB89851-58C9-46CA-896F-B50D1E55E87AQ34551567-6994ABC5-AF76-4F39-B833-BB1693F1DEE2Q35949786-0553F314-FE17-444C-8C1E-DEDD169C7AD9Q36259629-92FB29DA-87F5-4494-901F-13EBAA83131EQ36481002-F9DF1B77-4197-49C7-9D51-2BC51C535C9BQ36634261-BB17C652-2AD3-461C-92E3-86B5A1F1DC52Q36746141-395ACFE4-D5BF-404D-974E-D82DE1ECB395Q38497958-C1739E58-30B9-4065-BA5C-3061ED2047C2Q40066641-17B474B8-298E-4B79-9A12-9F7FC43146D4Q49887906-10F6544E-C636-4ECF-AEDC-904301675AFA
P2860
Dual inhibition of the epidermal growth factor and vascular endothelial growth factor phosphorylation for antivascular therapy of human prostate cancer in the prostate of nude mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Dual inhibition of the epiderm ...... in the prostate of nude mice.
@en
type
label
Dual inhibition of the epiderm ...... in the prostate of nude mice.
@en
prefLabel
Dual inhibition of the epiderm ...... in the prostate of nude mice.
@en
P2093
P2860
P356
P1433
P1476
Dual inhibition of the epiderm ...... in the prostate of nude mice.
@en
P2093
P2860
P304
P356
10.1002/PROS.20283
P577
2005-11-01T00:00:00Z